How has genetics changed the diagnosis and the management of differences of sex development?
Annales d'Endocrinologie · 2026-05 · 87 (3) · 102525
DOI: 10.1016/j.ando.2026.102525 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annales d'Endocrinologie, 2026-05. Verfasst von Claire Bouvattier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; Service d'endocrinolog…. Hauptthemen laut MEDLINE: Disorders of Sex Development, Sexual Development, Genetic Testing. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Rare differences of sex development (DSD) encompass all medical situations in which chromosomal sex, gonadal development, or external genitalia are atypical. Genetic investigations of these medical conditions, often diagnosed in the neonatal period, have evolved considerably over the past 20 years. Excluding congenital adrenal hyperplasia, whose diagnosis is clinical and hormonal, a genetic diagnosis is done in 2026 in only approximately 35% of DSD children with 46, XY and 46, XX DSD outside CAH, using next-generation sequencing (NGS) or genome analysis. In 2021, for the first time, a legal framework organizing the care of children with a variation in genital development (VGD), sometimes referred to as "intersex children" or "children with differences in sex development" (DSD), was introduced in France (article L. 2131-6 of the Code of Public Health). The law requires national multidisciplinary case review for any DSD children, except life-saving treatment, and put genetics at the center of the framework. Posterior/proximal hypospadias may, if clinically isolated and with a normal hormonal and genetic profile, fall outside this new framework. Children with 46, XY hypospadias, carrying a pathogenic variant fall within the scope of the law. This subtle distinction, lacking scientific support, makes family care pathways difficult to understand and therefore more distressing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; Service d'endocrinologie pédiatrique, hôpital Bicêtre, Le Kremlin-Bicêtre, France; Inserm, U…
- Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; Service d'endocrinologie pédiatrique, hôpital Bicêtre, Le Kremlin-Bicêtre, France.
- Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; Service de gynécologie adolescente et jeune adulte, hôpital Bicêtre, Le Kremlin-Bicêtre, Fra…
- Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; Service de médecine génomique et pharmacogénomique, hôpital Bicêtre, Le Kremlin-Bicêtre, Fra…
- Centre de référence des variations rares du développement génital DEV GEN, hôpital Bicêtre, AP-HP, Le Kremlin-Bicêtre, France; CNRS, UMR 8103, université Paris 1, Paris, France.
Zitieren
APA
Bouvattier, C., Fouatih, K., Duranteau, L., Bouligand, J., & Brunet, L. (2026). How has genetics changed the diagnosis and the management of differences of sex development?. Annales d'Endocrinologie, 87(3), 102525. https://doi.org/10.1016/j.ando.2026.102525
Vancouver
Bouvattier C, Fouatih K, Duranteau L, Bouligand J, Brunet L. How has genetics changed the diagnosis and the management of differences of sex development?. Annales d'Endocrinologie. 2026;87(3):102525. doi:10.1016/j.ando.2026.102525
BibTeX
@article{Bouvattier2026,
author = {Bouvattier, Claire and Fouatih, Khadidja and Duranteau, Lise and Bouligand, Jerôme and Brunet, Laurence},
title = {How has genetics changed the diagnosis and the management of differences of sex development?},
journal = {Annales d'Endocrinologie},
year = {2026},
volume = {87},
number = {3},
pages = {102525},
doi = {10.1016/j.ando.2026.102525}
}
EUVIMED